Nektar Therapeutics short interest in 2021
In 2021, Nektar Therapeutics's disclosed short interest ran from 13.36% of shares outstanding on 15 Jan 2021 to 10.28% on 31 Dec 2021, a change of -3.08 percentage points. The year's high was 13.36% on 15 Jan 2021 and its low 8.73% on 15 Oct 2021, averaging 10.18% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 30.15 days on 15 Apr 2021. Full history: Nektar Therapeutics.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 13.36% (15 Jan 2021)
- End of year
- 10.28% (31 Dec 2021)
- Change
- -3.08 pp
- High
- 13.36% (15 Jan 2021)
- Low
- 8.73% (15 Oct 2021)
- Average
- 10.18%
- Highest days to cover
- 30.15 (15 Apr 2021)
- SEC filings marked
- 9
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 13.36% | 27.05 | results (8-K) |
| 29 Jan 2021 | 12.76% | 20.09 | |
| 12 Feb 2021 | 11.80% | 13.72 | |
| 26 Feb 2021 | 11.84% | 13.87 | results (8-K), 10-K filed |
| 15 Mar 2021 | 11.12% | 20.56 | |
| 31 Mar 2021 | 10.74% | 23.92 | |
| 15 Apr 2021 | 10.97% | 30.15 | |
| 30 Apr 2021 | 10.55% | 26.69 | |
| 14 May 2021 | 9.93% | 17.08 | results (8-K), 10-Q filed |
| 28 May 2021 | 9.89% | 25.66 | |
| 15 Jun 2021 | 10.04% | 17.79 | |
| 30 Jun 2021 | 9.96% | 17.75 | |
| 15 Jul 2021 | 9.78% | 22.36 | |
| 30 Jul 2021 | 9.78% | 26.19 | |
| 13 Aug 2021 | 9.59% | 20.63 | results (8-K), 10-Q filed |
| 31 Aug 2021 | 9.44% | 18.97 | |
| 15 Sep 2021 | 8.96% | 21.83 | |
| 30 Sep 2021 | 8.81% | 16.29 | |
| 15 Oct 2021 | 8.73% | 17.05 | |
| 29 Oct 2021 | 8.83% | 19.77 | |
| 15 Nov 2021 | 9.12% | 9.24 | results (8-K), 10-Q filed |
| 30 Nov 2021 | 8.75% | 10.28 | |
| 15 Dec 2021 | 9.24% | 7.58 | |
| 31 Dec 2021 | 10.28% | 3.83 |
See also: Nektar Therapeutics's full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.